Reports on PTPN11 have focused on the development and prognosis of diseases such as promyelocytic leukemia [45, 46], myelodysplastic syndrome in children [46], ulcerative colitis [47], and gastric cancer [48]. This evidence concerns the gene PTPN11 and acute promyelocytic leukemia.